AI Insights · Timothy · July 2023
Top 5 Self-Therapy and Journaling Apps on Android in Peru: Q2 2023
Discover the performance trends of the top 5 self-therapy and journaling apps on the Android platform in Peru during the second quarter of 2023, based on data from Sensor Tower.
During the second quarter of 2023, the performance of the top 5 self-therapy and journaling apps on the Android platform in Peru showcased interesting trends. Here’s a closer look at their weekly downloads, revenue, and active users.
Daily Diary: My Journal Diary from Simple Design Ltd. saw a significant increase in weekly downloads, peaking at around 16K in mid-June. Active users also surged, reaching approximately 32K by the week of June 19.
SumOne: For Relationships by monymony corp. experienced fluctuating weekly downloads, with a notable peak at 8.6K in the final week of June. The app's weekly revenue remained low, with minor increments throughout the quarter. Active users exhibited a consistent upward trend, culminating at about 44.6K in the same period.
Fabulous Daily Routine Planner by TheFabulous maintained steady weekly downloads, with a slight increase reaching 3.4K in the last week of May. Weekly revenue saw a gradual rise, peaking at $336 during the final week of June. Active users demonstrated stability, hovering around 18K to 21K throughout the quarter.
Mininote by shaojie shi showed a variable download pattern, with a peak of 6.3K in late April. Active users followed a similar trend, peaking at around 13.4K in the same week, before stabilizing around 6K towards the end of June.
My Diary - Daily Diary Journal from Dairy App & Notes & Audio Editor & Voice Recorder displayed consistent weekly downloads, peaking at approximately 2.7K in the last week of June. Active users remained stable, with a slight increase to around 29.7K in early June. The weekly revenue showed minor fluctuations, peaking at $3 in late April.
These insights are based on data from Sensor Tower. For more comprehensive analysis and insights, visit Sensor Tower.